Open AccessMifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial
Author(s) -
Mikael Engman,
S. Granberg,
Alistair Williams,
ChunXia Meng,
Parameswaran Grace Lalitkumar,
Kristina GemzellDanielsson
Publication year - 2009
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dep100
Subject(s) - mifepristone , leiomyoma , medicine , placebo , randomized controlled trial , gynecology , uterine leiomyoma , surgery , pregnancy , biology , genetics , alternative medicine , pathology
Uterine leiomyomas are widely prevalent and frequently cause menorrhagia. The major therapeutic option today is hysterectomy. Medical options are of highest interest.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom